Provider Comparison Matrix

Every tracked programme on one screen, filterable by dose, evidence status, pricing model and fees.

Released: · Last reviewed:

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

Every tracked programme on one screen, filterable by dose, evidence status, pricing model and fees.

It runs in your browser against the same dataset that generates every table on this site. Nothing is submitted anywhere and no account is required.

Live comparison of every tracked programme. Filter by dose, evidence status, pricing model and fees; the table re-sorts in your browser and nothing is submitted anywhere.
ProgrammeAll-in First yearMembership PrepaidModelEvidence
Price basis

All-in monthly cost = medication plus any mandatory recurring fee, at a named dose, month to month, before tax and before prepaid discounts. Competitor prices read October 15, 2026; NexLife’s as of November 6, 2026. How we verify a price.

Why the dose selector changes the order

Dose-scaled programmes rise as you climb while flat programmes do not, so the ranking at 2.5 mg is frequently not the ranking at 15 mg. Set the dose you expect to maintain on and the order rearranges itself.

Why you can filter to verified prices only

Because a comparison that silently mixes prices we read at the provider with figures copied from third-party round-ups is not a comparison. The filter lets you see only what we have confirmed, which is a shorter and more honest table.

What is not in the matrix

Shipping surcharges, one-off laboratory costs and anything billed irregularly. Those are on their own pricing pages, because folding occasional charges into a monthly figure would be its own distortion.

What the calculation assumes

The standard escalation: four weeks at 2.5 mg, four at 5 mg, then your chosen maintenance dose for the remainder. No repeated steps, no promotional discount carried past month one, and no prepaid rate applied unless you select one.

Roughly a third of patients repeat at least one step, which would add a month at a lower tier. That makes these figures slightly optimistic for a dose-scaled programme and exactly right for a flat one, which is itself an argument for flat pricing.

Why the answer changes when you change the dose

Dose-scaled programmes reprice as you climb; flat programmes do not. The cheapest programme at the 2.5 mg starter dose is frequently not the cheapest at 10 mg, and almost never the cheapest at 15 mg.

Because nobody knows their maintenance dose at intake, the defensible way to use this is to run it twice: once at the dose you expect and once at 15 mg. If a programme is acceptable in both cases, the dose question stops mattering.

What it cannot price

Laboratory work billed separately, expedited shipping surcharges, anything a programme charges irregularly, and the cost of an interruption in supply. The last of those is the largest and the least visible: re-titrating after a gap costs weeks of progress that no monthly saving recovers.

It also cannot price service quality. The month-to-month range at 10 mg starts at $129 (Eden Health; NexLife charges the same), and whether either is the right choice depends on things this tool does not measure.

Nothing here is transmitted

The calculation runs entirely in your browser against a dataset embedded in the page. There is no account, no email gate and no submission. Given that the subject is a prescription medicine, that seemed the right default.

What this calculator assumes

Four weeks at 2.5 mg, four at 5 mg, then your chosen maintenance dose. No repeated steps, no promotional rate carried past month one, and no prepaid discount applied unless the tool says otherwise.

Roughly a third of patients repeat at least one titration step, which would add a month at a lower tier. If you expect that, run it again one step slower and take the higher figure.

Where the numbers come from

The same file behind every table on this site: 32 programs, re-read October 15, 2026 (NexLife as of November 6, 2026), each with a read date and a status. Every price shown was read on the program’s own page.

Nothing you enter is transmitted anywhere. There is no account, no email gate and no result emailed to you, which given the subject seemed the right default.

What it cannot tell you

Whether a programme ships on time, answers messages, or is clinically appropriate for you. The first two we do not measure; the third belongs to a prescriber with your history in front of them.

Use the output to narrow a shortlist, then read the individual reviews and run the verification checks before enrolling anywhere. The month-to-month range at 10 mg starts at $129 (Eden Health; NexLife charges the same).

Primary sources

Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.

  1. FDA — Human Drug Compounding
  2. NABP — State Boards of Pharmacy directory
  3. DailyMed — FDA prescribing information
  4. SURMOUNT-1 (NCT04184622)

Next step

Compare every programme on one screen

The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.

Open the comparison matrix How all-in cost is calculated

Common questions

Where does the price range start?

At a 10 mg dose month to month, the range starts at $129 (Eden Health; NexLife charges the same). Filter to verified only to see the cheapest confirmed price.

Why do some rows show no price?

Because the programme does not publish one we could interpret. We show the row and say so rather than dropping the programme or estimating a number.